Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 Feb;31(2):312–316. doi: 10.1128/aac.31.2.312

Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.

D L Stevens, B M Laine, J E Mitten
PMCID: PMC174712  PMID: 2882732

Abstract

The treatment of experimental gas gangrene caused by Clostridium perfringens was investigated by using combinations of antimicrobial agents. This study demonstrated that rifampin, penicillin, metronidazole, and clindamycin were all bactericidal against standard inocula (10(5) to 10(6) CFU). These antimicrobial agents were then administered to mice beginning 30 min after intramuscular injection of 10(9) CFU of C. perfringens type A. The highest doses used produced levels of drug in blood which exceeded the MIC by at least a factor of 40. In addition, other groups of mice received monotherapy at full dose or one-fourth full dose or combination antimicrobial therapy at full or one-fourth full dose. Among the single and combination antimicrobial treatments, metronidazole alone, clindamycin alone, and clindamycin plus penicillin were the most efficacious (P less than 0.05). Although the survival of mice treated with clindamycin plus penicillin was greater than that of mice treated with clindamycin alone, the difference did not reach statistical significance (P greater than 0.05). In contrast, mice treated with a combination of metronidazole and penicillin demonstrated greater mortality than those treated with metronidazole alone (P less than 0.05). In summary, combination antimicrobial therapy of experimental C. perfringens infection did not improve survival compared to that achieved with metronidazole or clindamycin alone, and some combinations significantly reduced survival (P less than 0.05).

Full text

PDF
312

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALTEMEIER W. A., McMURRIN J. A., ALT L. P. Chloromycetin and aureomycin in experimental gas gangrene. Surgery. 1950 Oct;28(4):621–631. [PubMed] [Google Scholar]
  2. Altemeier W. A., Fullen W. D. Prevention and treatment of gas gangrene. JAMA. 1971 Aug 9;217(6):806–813. [PubMed] [Google Scholar]
  3. Barry A. L., Lasner R. A. In-vitro methods for determining minimal lethal concentrations of antimicrobial agents. Am J Clin Pathol. 1979 Jan;71(1):88–92. doi: 10.1093/ajcp/71.1.88. [DOI] [PubMed] [Google Scholar]
  4. Brown P. W., Kinman P. B. Gas gangrene in a metropolitan community. J Bone Joint Surg Am. 1974 Oct;56(7):1445–1451. [PubMed] [Google Scholar]
  5. Darke S. G., King A. M., Slack W. K. Gas gangrene and related infection: classification, clinical features and aetiology, management and mortality. A report of 88 cases. Br J Surg. 1977 Feb;64(2):104–112. doi: 10.1002/bjs.1800640207. [DOI] [PubMed] [Google Scholar]
  6. Demello F. J., Haglin J. J., Hitchcock C. R. Comparative study of experimental Clostridium perfringens infection in dogs treated with antibiotics, surgery, and hyperbaric oxygen. Surgery. 1973 Jun;73(6):936–941. [PubMed] [Google Scholar]
  7. Dubreuil L., Devos J., Neut C., Romond C. Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics. Antimicrob Agents Chemother. 1984 Jun;25(6):764–766. doi: 10.1128/aac.25.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Irvin T. T., Moir E. R., Smith G. Treatment of Clostridium welchii infection with hyperbaric oxygen. Surg Gynecol Obstet. 1968 Nov;127(5):1058–1066. [PubMed] [Google Scholar]
  9. JAYKO L. G., LICHSTEIN H. C. Nutritional factors concerned with growth and lecithinase production by Clostridium perfringens. J Infect Dis. 1959 Mar-Apr;104(2):142–151. doi: 10.1093/infdis/104.2.142. [DOI] [PubMed] [Google Scholar]
  10. Joiner K. A., Onderdonk A. B., Gelfand J. A., Bartlett J. G., Gorbach S. L. A quantitative model for subcutaneous abscess formation in mice. Br J Exp Pathol. 1980 Feb;61(1):97–107. [PMC free article] [PubMed] [Google Scholar]
  11. Marrie T. J., Haldane E. V., Swantee C. A., Kerr E. A. Susceptibility of anaerobic bacteria to nine antimicrobial agents and demonstration of decreased susceptibility of Clostridium perfringens to penicillin. Antimicrob Agents Chemother. 1981 Jan;19(1):51–55. doi: 10.1128/aac.19.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mohr J. A., Griffiths W., Holm R., Garcia-Moral C., Flournoy D. J. Clostridial myonecrosis ('gas gangrene') during cephalosporin prophylaxis. JAMA. 1978 Feb 27;239(9):847–849. [PubMed] [Google Scholar]
  13. Nord C. E., Möllby R., Smyth C., Wadström T. Formation of phospholipase C and theta-haemolysin in pre-reduced media in batch anc continuous culture of Clostridium perfringens type A. J Gen Microbiol. 1974 Sep;84(1):117–127. doi: 10.1099/00221287-84-1-117. [DOI] [PubMed] [Google Scholar]
  14. Owen-Smith M. S., Matheson J. M. Successful prophylaxis of gas gangrene of the high-velocity missile wound in sheep. Br J Surg. 1968 Jan;55(1):36–39. doi: 10.1002/bjs.1800550111. [DOI] [PubMed] [Google Scholar]
  15. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schwartzman J. D., Reller L. B., Wang W. L. Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics. Antimicrob Agents Chemother. 1977 Apr;11(4):695–697. doi: 10.1128/aac.11.4.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stevens D. L., Maier K. A., Laine B. M., Mitten J. E. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis. 1987 Feb;155(2):220–228. doi: 10.1093/infdis/155.2.220. [DOI] [PubMed] [Google Scholar]
  18. Sutter V. L., Finegold S. M. Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrob Agents Chemother. 1976 Oct;10(4):736–752. doi: 10.1128/aac.10.4.736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Traub W. H. Clostridium perfringens type A. Comparison of in vitro and in vivo activity of twelve antimicrobial drugs. Chemotherapy. 1986;32(1):59–67. doi: 10.1159/000238389. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES